Harvard Infectious Diseases in Adults 2025

Overview

Harvard Infectious Diseases in Adults 2025 is a comprehensive on-demand education program presenting state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases in adult patients. This program delivers practical, evidence-based updates from nationally recognized infectious diseases experts, focusing on highly resistant infections, management of infections in immunocompromised hosts, emerging infectious diseases, and the latest in HIV and COVID-19 care.

On-demand infectious diseases education — accessible anytime, anywhere.

Format: 59 videos and 53 PDFs
Total size: 35.2 GB

Agenda

This program features a wide range of topics delivered through lectures, multidisciplinary workshops, and live question-and-answer sessions. Content includes case-based and problem-solving education with expert input from infectious diseases, pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine.

• Optimal decision-making for infectious diseases prevention, diagnosis, and treatment
• New antimicrobials and strategies for highly resistant infections including MRSA, ESBL-producing Gram-negative rods, carbapenemase producers, VRE, and fungal infections such as Aspergillus and Candida auris
• Updates on antifungal diagnostics and therapy
• Management of common infections: respiratory viral infections including COVID-19, systemic fungal infections, orthopedic infections, CNS infections, skin and soft tissue infections, HIV and related complications, sexually transmitted infections, hepatitis B and C, and vector-borne infections
• Emerging and re-emerging infectious diseases including highly pathogenic avian flu, Marburg virus, and vaccine-preventable diseases like poliomyelitis
• Clinical approaches to complex infections including infections in persons with substance use disorder
• Antimicrobial stewardship, infection control measures, and practice improvement strategies
• Multidisciplinary workshops on complicated urinary tract infections, intra-abdominal infections, endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections
• Updates on cellular and immune-based therapies for cancer patients regarding infection risk and management
• Recent vaccine developments, prevention strategies including PEP and PrEP for HIV and STIs
• Special sessions on critical care infectious diseases and tropical medicine

Target Audience

This program is designed for physicians, nurse practitioners, physician assistants, and pharmacists specializing in infectious diseases, hospital medicine, internal medicine, family practice, pulmonary and critical care medicine, and emergency medicine, as well as other healthcare professionals involved in the care of patients with infectious diseases.

Why This Topic Matters

Harvard Infectious Diseases in Adults 2025 provides essential updates for clinicians managing infectious diseases, emphasizing clinical relevance and the application of current guidelines and best practices. Staying informed on evolving pathogens, antimicrobial resistance, and preventive strategies is critical for improving patient care in infectious diseases and related specialties.

MedHub Central supports clinicians with accessible, expert-level infectious diseases education that strengthens knowledge and confidence in clinical decision-making across diverse practice settings. This program delivers comprehensive insights into emerging challenges and innovations in infectious diseases treatment and prevention.

Speakers

This program features lectures and workshops delivered by nationally recognized infectious diseases experts and master clinicians. The multidisciplinary faculty includes specialists from pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, offering a broad and integrated perspective on infectious diseases care.